Evidence map›Paper›PMID 23184930›Full record

ArticleThe Journal of biological chemistry2013

Alterations in the Ure2 αCap domain elicit different GATA factor responses to rapamycin treatment and nitrogen limitation.

Andre Feller, Isabelle Georis, Jennifer J Tate, Terrance G Cooper, Evelyne Dubois

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Next Generation Winemakers: Genetic Engineering inBioengineering (Basel, Switzerland) · 2020
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Applied and environmental microbiology · 2016
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Andre FellerInstitut de Recherches Microbiologiques J.-M. Wiame, Laboratoire de Microbiologie Université Libre de Bruxelles, B1070 Brussels, Belgium.
Isabelle Georis
Jennifer J Tate
Terrance G Cooper
Evelyne Dubois

Funding

SYNTHESIS AND ASSEMBLY OF EUKARYOTIC MEMBRANESR01GM035642 · NIGMS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI COOPER, TERRANCE G. · 1985 to 2015
$4.3M
NIGMS NIH HHS GM-35642-23A1NIGMS NIH HHS R01 GM035642
6 · The paper itself

Abstract

Ure2 is a phosphoprotein and central negative regulator of nitrogen-responsive Gln3/Gat1 localization and their ability to activate transcription. This negative regulation is achieved by the formation of Ure2-Gln3 and -Gat1 complexes that are thought to sequester these GATA factors in the cytoplasm of cells cultured in excess nitrogen. Ure2 itself is a dimer the monomer of which consists of two core domains and a flexible protruding αcap. Here, we show that alterations in this αcap abolish rapamycin-elicited nuclear Gln3 and, to a more limited extent, Gat1 localization. In contrast, these alterations have little demonstrable effect on the Gln3 and Gat1 responses to nitrogen limitation. Using two-dimensional PAGE we resolved eight rather than the two previously reported Ure2 isoforms and demonstrated Ure2 dephosphorylation to be stimulus-specific, occurring after rapamycin treatment but only minimally if at all in nitrogen-limited cells. Alteration of the αcap significantly diminished the response of Ure2 dephosphorylation to the TorC1 inhibitor, rapamycin. Furthermore, in contrast to Gln3, rapamycin-elicited Ure2 dephosphorylation occurred independently of Sit4 and Pph21/22 (PP2A) as well as Siw14, Ptc1, and Ppz1. Together, our data suggest that distinct regions of Ure2 are associated with the receipt and/or implementation of signals calling for cessation of GATA factor sequestration in the cytoplasm. This in turn is more consistent with the existence of distinct pathways for TorC1- and nitrogen limitation-dependent control than it is with these stimuli representing sequential steps in a single regulatory pathway.

Indexed as

Antifungal AgentsGATA Transcription FactorsGene Expression Regulation, FungalGlutathione PeroxidaseMutationNitrogenPrionsProtein Structure, TertiarySaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSignal TransductionSirolimusTranscription FactorsAntifungal AgentsGAT1 protein, S cerevisiaeGATA Transcription FactorsGLN3 protein, S cerevisiaeGlutathione PeroxidaseNitrogenPrionsSaccharomyces cerevisiae ProteinsSirolimusTORC1 protein complex, S cerevisiaeTranscription FactorsURE2 protein, S cerevisiae

Identifiers

PMID23184930
PMCPMC3548494

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.